| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/12/2011 | WO2011056240A2 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 05/12/2011 | WO2011056116A1 Composition for promoting wound healing |
| 05/12/2011 | WO2011056115A1 Lipid layer forming composition for administration onto a surface of a living organism |
| 05/12/2011 | WO2011055888A1 Nanoparticle-based gene delivery systems |
| 05/12/2011 | WO2011055385A1 Modified release formulation of lacosamide |
| 05/12/2011 | WO2011055379A1 A stable injectable pharmaceutical composition of aceclofenac and process for preparing thereof |
| 05/12/2011 | WO2011055375A1 Bioequivalent formulation of efavirenz |
| 05/12/2011 | WO2011055303A1 Tablet formulations of neratinib maleate |
| 05/12/2011 | WO2011055269A1 Delivery carrier |
| 05/12/2011 | WO2011055139A2 Formulations |
| 05/12/2011 | WO2011055083A2 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 05/12/2011 | WO2011055047A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding |
| 05/12/2011 | WO2011054930A2 Pharmaceutical solid dosage form |
| 05/12/2011 | WO2011054699A1 Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis |
| 05/12/2011 | WO2011054690A1 Stabilization of bio-sensors for in vivo applications |
| 05/12/2011 | WO2011054046A1 Controlled release particles and method for preparation thereof |
| 05/12/2011 | WO2011032992A3 Process for dewatering of product powders and pharmaceuticals compositions produced according to this process |
| 05/12/2011 | WO2011011300A3 Differentiation of human embryonic stem cells |
| 05/12/2011 | WO2011005853A3 Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome |
| 05/12/2011 | WO2010150982A9 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 05/12/2011 | WO2010144339A3 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
| 05/12/2011 | WO2010130896A3 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria |
| 05/12/2011 | WO2010100200A3 Lyophilised antibody formulation |
| 05/12/2011 | WO2010100179A3 Self-forming gel system for sustained drug delivery |
| 05/12/2011 | WO2010060624A3 Dry processing and novel forms of lacosamide |
| 05/12/2011 | WO2010017273A3 Tigecycline formulations |
| 05/12/2011 | WO2009135853A3 Encapsulation of biologically active agents |
| 05/12/2011 | US20110112481 Pivoting joint infusion system with seal |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112115 Polymeric microemulsions |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111043 Peptides and their use as carriers into cancer cells |
| 05/12/2011 | US20110111042 Self-microemulsifying systems incorporated into liquid core microcapsules |
| 05/12/2011 | US20110111041 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/12/2011 | US20110111040 Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier |
| 05/12/2011 | US20110111039 Compositions and Methods for Inhibiting Gastric Acid Secretion |
| 05/12/2011 | US20110111038 Process for producing a stable concentrated dietary supplement and supplement produced thereby |
| 05/12/2011 | US20110111037 Orodispersible mannitol |
| 05/12/2011 | US20110111036 Intracellular antibody delivery |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111034 Method and material for enhanced tissue-biomaterial integration |
| 05/12/2011 | US20110111033 Hydrogel with covalently crosslinked core |
| 05/12/2011 | US20110111032 Manufacturing method of collagen gel composition for bone regeneration |
| 05/12/2011 | US20110111031 Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| 05/12/2011 | US20110111030 Method of Producing Progenitor Cells from Differentiated Cells |
| 05/12/2011 | US20110111029 Composition for transdermal delivery of cationic active agents |
| 05/12/2011 | US20110111028 Composition and Methods For Repair of Connective Tissue |
| 05/12/2011 | US20110111027 Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| 05/12/2011 | US20110111026 Humidity-resistant drug formulations and methods of preparation thereof |
| 05/12/2011 | US20110111025 High Drug Load Formulations and Dosage Forms |
| 05/12/2011 | US20110111024 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 05/12/2011 | US20110111023 Prevention of type 1 diabetes by administration of gliadin |
| 05/12/2011 | US20110111022 Pharmaceutical formulation |
| 05/12/2011 | US20110111021 Pharmaceutical preparation |
| 05/12/2011 | US20110111020 Microcapsules Having Multiple Shells and Method for the Preparation Thereof |
| 05/12/2011 | US20110111019 Novel Method for Producing Nanocapsules in the Absence of an Organic Solvent, and Nanocapsules Produced Thereby |
| 05/12/2011 | US20110111018 Coated tablet formulations and uses thereof |
| 05/12/2011 | US20110111017 Use of immunogenic compositions for the treatment or prevention of pathogen infections |
| 05/12/2011 | US20110111016 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/12/2011 | US20110111015 Compositions and methods of enhancing immune responses to eimeria |
| 05/12/2011 | US20110111014 Methods and compositions for treatment of neurological disorders |
| 05/12/2011 | US20110111013 Transdermal therapeutic system for administration of fentanyl or an analogue thereof |
| 05/12/2011 | US20110111012 Nanomaterial wound dressing assembly |
| 05/12/2011 | US20110111011 Sublingual apomorphine |
| 05/12/2011 | US20110111010 Method and Composition for Burned Skin |
| 05/12/2011 | US20110111009 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 05/12/2011 | US20110111007 Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110111005 Biocompatible material and uses thereof |
| 05/12/2011 | US20110111004 Osteoinductive nanocomposites |
| 05/12/2011 | US20110111003 Stable cell binding chimeric peptides |
| 05/12/2011 | US20110111002 Transport and delivery of glutathione into human cells using gold nanoparticles |
| 05/12/2011 | US20110110996 Layer composite, suitable as a wound dressing, comprising a polyurethane foam layer, an absorber layer and a cover layer |
| 05/12/2011 | US20110110987 Agent for regenerating tympanic membrane or external auditory canal |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110985 Functionalized nanomaterials for chelation therapies and sorbent dialysis of toxins |
| 05/12/2011 | US20110110984 Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds |
| 05/12/2011 | US20110110869 Stable hydroalcoholic compositions |
| 05/12/2011 | US20110110868 Functionalized Magnetic Nanoparticles and Methods of Use Thereof |
| 05/12/2011 | CA2816401A1 Generation of antigenic virus-like particles through protein-protein linkages |
| 05/12/2011 | CA2789236A1 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 05/12/2011 | CA2780428A1 Tablet formulations of neratinib maleate |
| 05/12/2011 | CA2780332A1 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 05/12/2011 | CA2780268A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 05/12/2011 | CA2779797A1 Pharmaceutical solid dosage form |
| 05/12/2011 | CA2779720A1 Multilayer pharmaceutical composition that can be dispersed in water and which contains a combination of antimalarial agents |
| 05/12/2011 | CA2779433A1 Composition for promoting wound healing |
| 05/12/2011 | CA2779432A1 Lipid layer forming composition for administration onto a surface of a living organism |
| 05/12/2011 | CA2779424A1 Oral formulations of a hedgehog pathway inhibitor |
| 05/12/2011 | CA2779369A1 Composition, method, and kit for alpha-1 proteinase inhibitor |
| 05/12/2011 | CA2779147A1 Rosacea topical skin treatment method and formulation |
| 05/12/2011 | CA2779005A1 Delivery carrier |
| 05/12/2011 | CA2778698A1 An apparatus and method for simulating inhalation efforts |
| 05/12/2011 | CA2778361A1 Stabilization of bio-sensors for in vivo applications |
| 05/12/2011 | CA2778273A1 Fast dissolving/disintegrating coating compositions |
| 05/12/2011 | CA2778003A1 Stable thickener formulations |
| 05/12/2011 | CA2775599A1 Bazedoxifene formulations with antioxidants |
| 05/11/2011 | EP2319894A1 Novel lipid dipeptide and gel |
| 05/11/2011 | EP2319858A1 Aqueous suspensions of ciclesonide for nebulisation |